Florida TMS Clinic · Wesley Chapel & Tampa
Does Insurance Cover TMS Therapy in Florida?
Medically reviewed by Dr. Khaled Bowarshi, M.D., board-certified psychiatristUpdated November 1, 2026
Many insurance plans cover transcranial magnetic stimulation (TMS) for depression when their medical necessity requirements are met. At Florida TMS Clinic, we help patients in Wesley Chapel and Tampa understand their benefits, treatment requirements, and expected costs before starting care.
If medications have not helped enough—or side effects have made them difficult to take—an insurance coverage check can help you understand your options.
Call (813) 867-2378 or complete the form below to request a TMS coverage check.
Key takeaways
Many plans cover TMS for qualifying depression. Your diagnosis, symptoms, and treatment history help determine eligibility.
Medication requirements vary. Some patients qualify after one unsuccessful medication trial; other plans require additional trials, psychotherapy, or augmentation.
The exact plan and treatment protocol matter. Commercial coverage, Medicare Advantage, Medicaid, repeat courses, and shorter or accelerated protocols can have different rules.
We help you understand the next step. Our team verifies benefits, checks authorization requirements, and explains estimated out-of-pocket costs before treatment.
Many insurance plans cover TMS
Logos belong to their owners. Coverage depends on your plan, so we check your benefits first.
Who qualifies for insurance-covered TMS?
Coverage is most commonly available for major depressive disorder that has not improved enough with medication. Insurers may review:
- A confirmed diagnosis and documented symptom severity.
- Medication names, classes, doses, dates, results, and side effects.
- Psychotherapy history, when required.
- Previous response to TMS, if you have received it before.
- Depression rating scales used to document symptoms and progress.
- The proposed device, treatment protocol, and clinical evaluation.
A medication “trial” generally means taking a medication at a qualifying dose for an adequate period. Documented intolerance may provide an alternative pathway under some policies. Insurers can also require trials during the current depressive episode or within a specified period.
Augmentation means adding another medication to an antidepressant to improve its effect. An antidepressant class is a group of medications that work in a similar way.
You do not need to determine eligibility on your own. Our team reviews your history against the requirements that apply to your specific coverage.
Compare TMS insurance coverage in Florida
The table below compares initial eligibility, treatment requirements, and repeat-course criteria across common plans.
How to read the table: MDD means major depressive disorder. Medication, psychotherapy, and augmentation entries summarize adult requirements; adolescent differences appear below. “Not separately listed” means the cited policy does not state a distinct requirement in that category. It does not establish coverage by itself.
Commercial and Medicare Advantage policies are different. Medicare Advantage plans must follow applicable Medicare coverage criteria and may have their own authorization and network procedures.
Scroll sideways to see every column. The plan name stays in view.
| Insurance plan | Eligibility | Treatment requirements | Course and approval | Repeat course and notes | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Policy age | Depression indication | Medication history — adults | Medication trial duration | Psychotherapy | Augmentation | Symptom ratings | Prior authorization | Standard course | Prior response for repeat treatment | Repeat-treatment timing | Protocol limits and other notes | |
| Original Medicare — Florida | Adults | Severe MDD, single or recurrent | At least 1 adequate failed trial and/or documented intolerance | Adequate dose and duration; no fixed week minimum | Not separately listed in initial criteria | Not separately listed in initial criteria | Clinical severity documented; no named scale/cutoff mandated | Not specified in LCD; verify current requirements | Up to 6 weeks under the LCD | Individual medical-necessity review; no explicit threshold published | No fixed repeat-course interval published | Psychiatrist face-to-face evaluation and order; OCD excluded |
| Florida Blue / Lucet — commercial | 15–70 | Severe MDD without psychosis | 2 failed trials from 2 classes, OR 2 intolerable trials from 2 classes | No fixed minimum in eligibility section | History requested; no universal trial requirement listed in policy | Not separately listed | PHQ-9 ≥20 or another listed threshold; baseline, every 2 weeks, and final | Required under Lucet authorization process | 30 treatments + 6 taper sessions | At least 50% improvement; initial criteria still met | At least 90 days after previous course ends | iTBS, OCD, and maintenance excluded; alternative ECT-based eligibility pathway exists |
| UnitedHealthcare / Optum — non-Medicare | 15+ | MDD; listed covered codes describe severe, nonpsychotic depression | 2 regimens from 2 classes during current episode; qualifying prior TMS response is another pathway | No fixed week minimum in eligibility section | Not separately required | Not separately required | Baseline validated depression scale | Required for applicable plans; verify member benefits | 30 treatments + 6 taper sessions | More than 50% improvement; relapse despite ongoing care | Relapse 6 months after most recent treatment | TBS, accelerated protocols, OCD, and maintenance/boosters excluded |
| Cigna / Evernorth — commercial | 15+ | Moderate-to-severe unipolar MDD without psychosis | 2 antidepressant trials from 2 classes during current episode; intolerance/contraindication can qualify | At least 4 weeks, unless intolerance/contraindication applies | Yes; adequate evidence-based trial without significant improvement | Not separately required | Validated scale at beginning and end of each course | Waived for contracted providers under applicable plans; exceptions apply | 30–36 treatments | More than 50% improvement | Improvement maintained at least 2 months before relapse | Maintenance and accelerated protocols excluded; clarify daily iTBS coverage |
| Aetna — commercial | 15+ | Severe MDD without psychosis | 2 antidepressants from 2 classes; current-episode/five-year provision applies | At least 8 weeks each at qualifying therapeutic doses | Adults: not separately required; adolescents: psychotherapy OR augmentation | Adults: yes, at least 8 weeks; adolescent alternative described below | Same validated scale at baseline and during treatment | Generally required; verify member plan | 30 treatments + 6 taper; additional sessions individually reviewed | At least 50% improvement; relapse despite other appropriate care | Improvement maintained at least 2 months; no repeat within 60 days | FDA-cleared iTBS included; accelerated, OCD, and maintenance excluded |
| Humana Medicare Advantage — Florida framework | Adults under applicable Medicare criteria | Severe MDD under Florida LCD | Applicable Medicare criteria; Florida LCD allows ≥1 failure and/or intolerance | Adequate dose/duration under Medicare criteria | Not separately listed in Florida LCD initial criteria | Not separately listed in Florida LCD initial criteria | Document severity; verify plan documentation requirements | Generally required; product-specific exceptions apply | Confirm Medicare-based course with plan | Individual review under applicable Medicare/plan criteria | Confirm with plan; no universal Humana interval established here | Medicare Advantage requirements must be checked separately from Humana Medicaid |
| TRICARE East / Humana Military | 18+ | Severe MDD, single or recurrent | Inadequate response to 2 antidepressant classes, OR intolerance of at least 2 agents | Adequate dose, duration, and adherence; no fixed week minimum stated | Not separately listed in cited policy | Not separately listed in cited policy | Standardized scale, such as PHQ-9, BDI, HAM-D, or MADRS | Required | Typically 5 days/week for 4–6 weeks; confirm authorized units | At least 50% improvement, followed by relapse | No fixed minimum interval stated | More than 1 treatment/day is unproven; other indications not covered under cited policy |
| Ambetter from Sunshine Health | 18+; ages 15–17 receive case review | Severe MDD | 2 failed trials from 2 classes, OR 4 intolerable trials from at least 2 classes | Failed trials: at least 6 weeks each within last 24 months | Yes; should overlap medication trials | Not separately required | PHQ-9 ≥15 or equivalent; baseline and ongoing monitoring | Plan-specific; verify through Florida preauthorization process | Up to 36 treatments, including optional 6-session taper | At least 50% improvement; relapse to PHQ-9 ≥15/equivalent; case review | Prior benefit documented for 6 months | Adult iTBS included; maintenance excluded; MRI-guided accelerated TBS unsupported |
Original Medicare — Florida
Eligibility
- Policy age
- Adults
- Depression indication
- Severe MDD, single or recurrent
Treatment requirements
- Medication history — adults
- At least 1 adequate failed trial and/or documented intolerance
- Medication trial duration
- Adequate dose and duration; no fixed week minimum
- Psychotherapy
- Not separately listed in initial criteria
- Augmentation
- Not separately listed in initial criteria
- Symptom ratings
- Clinical severity documented; no named scale/cutoff mandated
Course and approval
- Prior authorization
- Not specified in LCD; verify current requirements
- Standard course
- Up to 6 weeks under the LCD
Repeat course and notes
- Prior response for repeat treatment
- Individual medical-necessity review; no explicit threshold published
- Repeat-treatment timing
- No fixed repeat-course interval published
- Protocol limits and other notes
- Psychiatrist face-to-face evaluation and order; OCD excluded
Florida Blue / Lucet — commercial
Eligibility
- Policy age
- 15–70
- Depression indication
- Severe MDD without psychosis
Treatment requirements
- Medication history — adults
- 2 failed trials from 2 classes, OR 2 intolerable trials from 2 classes
- Medication trial duration
- No fixed minimum in eligibility section
- Psychotherapy
- History requested; no universal trial requirement listed in policy
- Augmentation
- Not separately listed
- Symptom ratings
- PHQ-9 ≥20 or another listed threshold; baseline, every 2 weeks, and final
Course and approval
- Prior authorization
- Required under Lucet authorization process
- Standard course
- 30 treatments + 6 taper sessions
Repeat course and notes
- Prior response for repeat treatment
- At least 50% improvement; initial criteria still met
- Repeat-treatment timing
- At least 90 days after previous course ends
- Protocol limits and other notes
- iTBS, OCD, and maintenance excluded; alternative ECT-based eligibility pathway exists
UnitedHealthcare / Optum — non-Medicare
Eligibility
- Policy age
- 15+
- Depression indication
- MDD; listed covered codes describe severe, nonpsychotic depression
Treatment requirements
- Medication history — adults
- 2 regimens from 2 classes during current episode; qualifying prior TMS response is another pathway
- Medication trial duration
- No fixed week minimum in eligibility section
- Psychotherapy
- Not separately required
- Augmentation
- Not separately required
- Symptom ratings
- Baseline validated depression scale
Course and approval
- Prior authorization
- Required for applicable plans; verify member benefits
- Standard course
- 30 treatments + 6 taper sessions
Repeat course and notes
- Prior response for repeat treatment
- More than 50% improvement; relapse despite ongoing care
- Repeat-treatment timing
- Relapse 6 months after most recent treatment
- Protocol limits and other notes
- TBS, accelerated protocols, OCD, and maintenance/boosters excluded
Cigna / Evernorth — commercial
Eligibility
- Policy age
- 15+
- Depression indication
- Moderate-to-severe unipolar MDD without psychosis
Treatment requirements
- Medication history — adults
- 2 antidepressant trials from 2 classes during current episode; intolerance/contraindication can qualify
- Medication trial duration
- At least 4 weeks, unless intolerance/contraindication applies
- Psychotherapy
- Yes; adequate evidence-based trial without significant improvement
- Augmentation
- Not separately required
- Symptom ratings
- Validated scale at beginning and end of each course
Course and approval
- Prior authorization
- Waived for contracted providers under applicable plans; exceptions apply
- Standard course
- 30–36 treatments
Repeat course and notes
- Prior response for repeat treatment
- More than 50% improvement
- Repeat-treatment timing
- Improvement maintained at least 2 months before relapse
- Protocol limits and other notes
- Maintenance and accelerated protocols excluded; clarify daily iTBS coverage
Aetna — commercial
Eligibility
- Policy age
- 15+
- Depression indication
- Severe MDD without psychosis
Treatment requirements
- Medication history — adults
- 2 antidepressants from 2 classes; current-episode/five-year provision applies
- Medication trial duration
- At least 8 weeks each at qualifying therapeutic doses
- Psychotherapy
- Adults: not separately required; adolescents: psychotherapy OR augmentation
- Augmentation
- Adults: yes, at least 8 weeks; adolescent alternative described below
- Symptom ratings
- Same validated scale at baseline and during treatment
Course and approval
- Prior authorization
- Generally required; verify member plan
- Standard course
- 30 treatments + 6 taper; additional sessions individually reviewed
Repeat course and notes
- Prior response for repeat treatment
- At least 50% improvement; relapse despite other appropriate care
- Repeat-treatment timing
- Improvement maintained at least 2 months; no repeat within 60 days
- Protocol limits and other notes
- FDA-cleared iTBS included; accelerated, OCD, and maintenance excluded
Humana Medicare Advantage — Florida framework
Eligibility
- Policy age
- Adults under applicable Medicare criteria
- Depression indication
- Severe MDD under Florida LCD
Treatment requirements
- Medication history — adults
- Applicable Medicare criteria; Florida LCD allows ≥1 failure and/or intolerance
- Medication trial duration
- Adequate dose/duration under Medicare criteria
- Psychotherapy
- Not separately listed in Florida LCD initial criteria
- Augmentation
- Not separately listed in Florida LCD initial criteria
- Symptom ratings
- Document severity; verify plan documentation requirements
Course and approval
- Prior authorization
- Generally required; product-specific exceptions apply
- Standard course
- Confirm Medicare-based course with plan
Repeat course and notes
- Prior response for repeat treatment
- Individual review under applicable Medicare/plan criteria
- Repeat-treatment timing
- Confirm with plan; no universal Humana interval established here
- Protocol limits and other notes
- Medicare Advantage requirements must be checked separately from Humana Medicaid
TRICARE East / Humana Military
Eligibility
- Policy age
- 18+
- Depression indication
- Severe MDD, single or recurrent
Treatment requirements
- Medication history — adults
- Inadequate response to 2 antidepressant classes, OR intolerance of at least 2 agents
- Medication trial duration
- Adequate dose, duration, and adherence; no fixed week minimum stated
- Psychotherapy
- Not separately listed in cited policy
- Augmentation
- Not separately listed in cited policy
- Symptom ratings
- Standardized scale, such as PHQ-9, BDI, HAM-D, or MADRS
Course and approval
- Prior authorization
- Required
- Standard course
- Typically 5 days/week for 4–6 weeks; confirm authorized units
Repeat course and notes
- Prior response for repeat treatment
- At least 50% improvement, followed by relapse
- Repeat-treatment timing
- No fixed minimum interval stated
- Protocol limits and other notes
- More than 1 treatment/day is unproven; other indications not covered under cited policy
Ambetter from Sunshine Health
Eligibility
- Policy age
- 18+; ages 15–17 receive case review
- Depression indication
- Severe MDD
Treatment requirements
- Medication history — adults
- 2 failed trials from 2 classes, OR 4 intolerable trials from at least 2 classes
- Medication trial duration
- Failed trials: at least 6 weeks each within last 24 months
- Psychotherapy
- Yes; should overlap medication trials
- Augmentation
- Not separately required
- Symptom ratings
- PHQ-9 ≥15 or equivalent; baseline and ongoing monitoring
Course and approval
- Prior authorization
- Plan-specific; verify through Florida preauthorization process
- Standard course
- Up to 36 treatments, including optional 6-session taper
Repeat course and notes
- Prior response for repeat treatment
- At least 50% improvement; relapse to PHQ-9 ≥15/equivalent; case review
- Repeat-treatment timing
- Prior benefit documented for 6 months
- Protocol limits and other notes
- Adult iTBS included; maintenance excluded; MRI-guided accelerated TBS unsupported
These are policy summaries, not a complete statement of benefits or eligibility. A repeat-course response threshold or elapsed interval is only part of the approval criteria. When no fixed requirement is published, individual review or plan confirmation is needed. Federal employee plans, out-of-state policies, and employer-specific arrangements may use different guidelines.
About symptom ratings: PHQ-9 and other depression scales help measure symptoms and treatment response. Your clinician selects and interprets the appropriate assessment.
Important differences behind the table
Medicare in Florida: The relevant Original Medicare policy is First Coast’s LCD L34522. Other Medicare regions can use different policies. Florida’s rule should be applied when evaluating the Florida Medicare framework.
Florida Blue: Its dedicated Lucet policy differs from Lucet’s general TMS policy. The ages, symptom-rating requirements, and protocol limitations shown above refer to the Florida Blue policy.
Humana: We identify whether coverage is Medicare Advantage or Medicaid and check the appropriate clinical criteria, benefits, and approval process.
Cigna authorization update: Effective March 6, 2026, prior authorization was removed for TMS provided by Evernorth-contracted providers under applicable Cigna/Evernorth plans. Out-of-network providers and network exception requests generally still require authorization. Benefits and network status still need verification.
Can adolescents qualify for TMS coverage?
Some plans include patients starting at age 15, but medication and treatment requirements can differ from the adult rules.
- Optum/UHC: Ages 15–17 require two unsuccessful or intolerable evidence-based medication regimens; the adult two-class requirement is not stated for this age group.
- Cigna/Evernorth: Adolescents require two antidepressant trials and unsuccessful evidence-based psychotherapy.
- Aetna: Ages 15–17 require two antidepressant trials lasting at least eight weeks each, plus psychotherapy or qualifying augmentation. TMS must be used alongside an antidepressant.
- Ambetter: Ages 15–17 receive case-by-case review. Its adolescent intolerance pathway uses two medication trials rather than the adult four-trial requirement; device and other eligibility restrictions apply.
The plan’s age criteria and the FDA-cleared indication for the proposed device both need review.
What will TMS cost with insurance?
Your estimated out-of-pocket cost depends on:
- Your remaining deductible.
- Copayments or coinsurance.
- Your clinic and provider’s network participation.
- Your plan’s in-network out-of-pocket maximum.
- The approved treatment course and any benefit limitations.
Our team checks these details and explains your estimated responsibility before treatment begins. Costs can differ between patients who have insurance through the same company because their individual benefits differ.
How we help with insurance
- 1
Identify your specific plan. We review your insurance information and determine who administers your behavioral health benefits.
- 2
Review your treatment history. We help gather the medication, psychotherapy, symptom-rating, and previous TMS information needed to evaluate eligibility.
- 3
Check coverage and authorization. We verify network participation and prepare a prior authorization request when required.
- 4
Explain costs and next steps. We discuss your estimated responsibility and recommended treatment plan before you begin.
If a request is denied, we can review the reason, identify missing information, and discuss whether reconsideration or an appeal is appropriate.
Frequently asked questions
Not always. The number of trials depends on your plan and the reason previous treatment was unsuccessful. Some policies accept one trial; many require two or additional treatment steps.
The table summarizes the main differences. A coverage review can establish which requirements apply to you.
They can under several policies. Your records should describe the medication, dose, dates, side effects, and why treatment could not continue.
Insurers do not necessarily count intolerance the same way they count a completed trial without sufficient benefit. The required number of trials and documentation can differ.
Some plans require an adequate trial of evidence-based psychotherapy. Other policies do not list it as a separate initial requirement, or use different rules for adolescents.
Tell us about previous therapy, including the type, frequency, duration, and results, so we can evaluate the applicable criteria.
Another acute course may be covered when you previously benefited and later experience a relapse. Your insurer may require documented improvement on a symptom scale, a sustained period of benefit, and evidence that you meet current treatment criteria.
A waiting period and a sustained response are different requirements. Reaching a certain date does not by itself establish eligibility. We review your previous response, how long it lasted, your current symptoms, and ongoing treatment.
Many policies exclude scheduled maintenance or booster TMS even when they cover an initial course. A new acute course after a documented relapse is evaluated separately.
Some plans have separate coverage pathways for obsessive-compulsive disorder, including Cigna/Evernorth and certain Centene-affiliated plans. These require their own medication, psychotherapy, symptom-rating, and device/protocol criteria.
OCD coverage should be verified separately from depression coverage. FDA clearance alone does not establish insurance coverage.
TMS may be covered when you have qualifying MDD and meet your plan’s requirements, even when anxiety symptoms are also present. Treatment for an anxiety disorder on its own generally falls outside the policies summarized here.
Intermittent theta-burst stimulation (iTBS) uses shorter sessions. An accelerated schedule involves multiple treatments per day. Insurers can treat these protocols differently.
Some policies include daily iTBS, while others exclude TBS. Accelerated and MRI-guided protocols can face additional exclusions. We check coverage for the actual treatment being recommended.
Many commercial policies describe approximately 30 treatments plus up to six taper sessions. Other policies use a different session range or course duration.
Your approved schedule depends on the governing policy and clinical circumstances. Additional sessions may require a separate review.
The company on your card may use another organization to administer behavioral health benefits. Some Oscar and AvMed plans use Optum.
We identify the appropriate administrator and confirm the requirements for your particular plan.
Coverage, provider participation, and authorization depend on the specific Medicaid managed care plan. A published clinical policy or authorization-tool listing does not by itself establish that a service is covered for an individual member.
Contact us with your plan information so we can check the relevant benefits and participation requirements.
Check your TMS coverage
If depression has not improved enough with medication, an insurance coverage check can help you understand whether TMS is an option.
Florida TMS Clinic provides TMS care in Wesley Chapel and Tampa. Our team can review your benefits, explain treatment requirements, and help you understand the next step.
Call (813) 867-2378 or complete the form below to request your coverage check.
Policy information checked November 1, 2026. Coverage depends on your specific benefits, applicable medical policy, clinical circumstances, network participation, and any required authorization. Benefit verification and authorization do not guarantee claim payment.
Official policy references
- Original Medicare in Florida — First Coast LCD L34522
- First Coast — billing and documentation article A57647
- Florida Blue — Lucet 2026 TMS policy
- Lucet — 2026 authorization form and medical policy resources
- Optum — TMS clinical policy
- Optum — Florida authorization resources
- Cigna/Evernorth — TMS coverage policy
- Cigna/Evernorth — prior authorization update
- Aetna — TMS clinical policy
- Aetna — behavioral health precertification list
- Humana — Medicare Advantage authorization requirements
- CMS — Medicare Advantage coverage criteria guidance
- TRICARE East — Humana Military TMS policy
- Ambetter — TMS for depression
- Ambetter — TMS for OCD
- Ambetter Florida — prior authorization guide